Loading…
The proposal was announced by the company on a recent date.
Seer, Inc., a biotechnology company, announced it has received an unsolicited acquisition proposal from Omid Farokhzad, M.D., a notable figure in the industry.
The proposal was communicated to the company, marking a significant development in its corporate strategy. Further details regarding the terms and conditions of the proposal have not been disclosed.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.